Cwm, LLC Relmada Therapeutics, Inc. Transaction History

Cwm, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$2.22 - $3.54 $175 - $279	-79 Reduced 11.24%	624 $2,000
Q1 2023 Apr 28, 2023	BUY	$2.24 - $4.76 $938 - $1,994	419 Added 147.54%	703 $2,000
Q4 2022 Feb 01, 2023	BUY	$2.17 - $35.84 $575 - $9,497	265 Added 1394.74%	284 $1,000
Q4 2021 Jan 31, 2022	BUY	$16.93 - $26.82 $321 - $509	19 New	19 $0

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.